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Association of Gene Polymorphism of the Fat Mass and 
Obesity Associated Gene with Metabolic Syndrome:  
A Retrospective Cohort Study in Japanese Workers
Tomoka Kawajiri, Yoneatsu Osaki and Takuji Kishimoto
Division of Environmental and Preventive Medicine, Department of Social Medicine, School of Med-
icine, Tottori University Faculty of Medicine, Yonago 683-8503, Japan
To investigate whether gene polymorphism of the fat mass and obesity associated gene 
(FTO) is associated with metabolic syndrome (MS), we used two MS criteria, the National 
Cholesterol Education Program-Adult Treatment panel III (NCEP-ATPIII) definition in 
2003 and the Japanese definition in 2005. Subjects were respectively 859 and 865 Japanese 
workers at a company in Shimane Prefecture, Japan. They were non-MS individuals in 
1998 and had regular health checkups between 1998 and 2006. The Cox proportional haz-
ard regression was used to predict MS. Three SNPs in the FTO, rs9939609, rs1121980 and 
rs1558902, were genotyped by the TaqMan PCR assay and a retrospective study was per-
formed. The three SNPs in the FTO were significantly associated with body mass index, 
and rs1121980 and rs1558902 were associated with fasting plasma glucose. MS defined 
by the NCEP-ATPIII definition was significantly associated with additive and dominant 
models of rs9939609 and rs1121980, and the dominant model of rs1558902, even after ad-
justing for confounding factors such as age, sex and lifestyle. MS defined by the Japanese 
definition was significantly associated with the additive model of rs1121980 and additive 
and dominant models of rs1558902 in multivariate analysis. These results suggested that 
FTO gene polymorphisms, rs9939609, rs1121980 and rs1558902, were associated with an 
increased risk of MS among Japanese workers. 
Key words: cohort study; fat mass and obesity associated gene; Japanese worker; metabolic syn-
drome; single nucleotide polymorphism
Abbreviations: BMI, body mass index; BP, blood pressure; FPG, fasting plasma glucose; FTO, fat mass and obesity associat-
ed gene; HDL, high density lipoprotein; MS, metabolic syndrome; NCEP-ATPIII, National Cholesterol Education Program-
Adult Treatment panel III; SNP, single nucleotide polymorphism; T2DM, type 2 diabetes mellitus. 
Metabolic syndrome (MS) is a cluster of risk factors 
for developing cardiovascular disease such as type 
2 diabetes mellitus (T2DM), consisting of central 
obesity, high blood pressure, abnormal glucose 
tolerance and abnormal lipid profiles (Eckel et al., 
2005; Grundy et al., 2005). The prevalence of MS 
has become increasingly common not only in Japan, 
but also in the world. It is because environmental fac-
tors contribute to the increased prevalence of MS, 
namely lifestyles (Fappa et al., 2008), and genetic 
factors are also related (Groop, 2000; Eckel et al., 
2005).
 Recently, part of a genome-wide association 
study found that several single nucleotide poly-
morphisms (SNPs) of the fat mass and obesity as-
sociated gene (FTO) were strongly associated with 
obesity and T2DM (Hinney et al., 2007; Scuteri et 
al., 2007). 
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The human FTO is located on chromosome no.16 
(16q12.2), which consists of 9 exons with an entire 
length of 410 kb (410,507 bp). The FTO encodes a 
2-oxoglutarate-dependent nucleic acid demethylase 
and is widely expressed in many tissues, especially 
in the hypothalamus, which controls energy balance 
(Dina et al., 2007; Frayling et al., 2007). Studies in 
mice indicated that FTO mRNA levels were regu-
lated by feeding and fasting (Gerken et al., 2007), 
and FTO knockout mice had postnatal growth 
delays, increased energy consumption and skinny 
body shapes (Fischer et al., 2009). Thus, the FTO 
may play an important role in controlling energy 
expenditure and may also be involved in energy 
homeostasis, but the exact function of the FTO and 
the mechanisms by which the FTO involves biologi-
cal pathways remain unknown.
 In previous genetic analyses, SNPs rs9939609, 
rs1121980 and rs1558902, located in intron1 of the 
FTO were strongly associated with obesity, BMI 
and MS in Caucasians and Hispanic Americans 
(Dina et al., 2007; Frayling et al., 2007; Hinney 
et al., 2007; Scuteri et al., 2007; Al-Attar et al., 
2008; Andreasen et al., 2008; Sjögren et al., 2008; 
González-Sánchez et al., 2009), but not in African 
American, Oceanic or Chinese populations (Ohashi 
et al., 2007; Scuteri et al., 2007; Li et al., 2008). 
These reports suggest that the FTO is a race-specific 
gene. Studies in the Japanese failed to establish con-
sistency in the association between FTO SNPs and 
obesity (Horikoshi et al., 2007; Omori et al., 2008; 
Hotta et al., 2010; Karasawa et al., 2010; Shimaoka 
et al., 2010). Concerning the Japanese, few reports 
indicated the association of FTO SNPs with MS, 
and some denied (Tabara et al., 2009; Shimaoka et 
al., 2010).
 Therefore, in the present study, we analyzed 
the relationship between FTO SNPs, rs9939609, 
rs1121980 and rs1558902, and MS diagnosed by 
the NCEP-ATPIII and Japanese definitions among 
Japanese workers. To investigate the association in 
a more detailed manner than previous reports, a ret-
rospective cohort study enrolling lifestyle factors as 
considerable variables was performed.
 
 
Materials and Methods
Subjects
 
Subjects consisted of 859 persons (486 males and 
373 females) and 865 persons (498 males and 367 
females) under the NCEP-ATPIII and Japanese 
definitions for MS, respectively. They were employ-
ees of an industry in the Izumo region of Shimane 
Prefecture in Japan who had consistently undergone 
health check-ups between 1998 and 2006 and were 
non-MS individuals in 1998. The average age (± 
SD) was 37.69 ± 8.74 years for the subjects under 
NCEP-ATPIII and 37.75 ± 8.72 years for those un-
der the Japanese definition. A retrospective cohort 
study of the relationship between FTO polymor-
phism and the prevalence of MS for the period be-
tween 1998 and 2006 was performed. All subjects 
gave written informed consent to participate in the 
study. The study protocol was approved by the Eth-
ics Committee of Tottori University (permission 
number, G63).
 Subjects completed health check-ups consist-
ing of measurements of the height, weight, body 
mass index (BMI), blood pressure (BP) and his-
tory taking (drinking, smoking, eating, exercise 
and sleeping habits). The BMI was calculated as 
the weight in kilogram divided by the square of 
the height in meter. Obesity was defined as a BMI 
≥ 25.0 kg/m2, as defined by the Japan Society of 
Obesity. Blood pressure was measured once on the 
health-check day in a sitting position with a stan-
dard sphygmomanometer. The first and fifth Ko-
rotkoff sounds were used to determine systolic BP 
and diastolic BP, respectively. Blood tests included 
high-density lipoprotein (HDL) cholesterol, triglyc-
erides and fasting plasma glucose (FPG). Plasma 
glucose levels were determined by the hexokinase-
G-6-PDH method (Wako, Tokyo, Japan.) We in-
vestigated lifestyles, alcohol drinking habits (no 
drinking, occasionally, nearly every day), cigarette 
smoking habits (no smoking, quit, smoking), eating 
habits (eat various food, consider balance slightly, 
rarely consider balance), exercise habits (frequently, 
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sometimes, no exercise) and sleeping habits (suffi-
ciency, usual, insufficiency). 
Definition of metabolic syndrome
 
The NCEP-ATP III definition includes the presence 
of three or more of the following five criteria: cen-
tral obesity (waist circumference ≥ 90 cm for males, 
≥ 80 cm for females), elevated BP (systolic ≥ 130 
mmHg or diastolic ≥ 85 mmHg), elevated triglycer-
ides (≥ 150 mg/dL), reduced HDL cholesterol (< 40 
mg/dL for males, < 50 mg/dL for females), and el-
evated FPG (≥ 110 mg/dL). However, in this study, 
central obesity was defined as a BMI > 25 kg/m2, as 
defined by the Japan Society of Obesity. A previous 
diagnosis of T2DM was considered to be evidence 
of an elevated FPG. 
 The Japanese definition includes the same five 
criteria as the NCEP-ATPIII definition, but raised 
triglycerides and/or reduced HDL cholesterol levels 
are regarded as a single dyslipidemia criterion. In 
addition, central obesity must be present as well as 
two or more of the other four factors. The Japanese 
definition includes: waist circumference ≥ 85 cm for 
males and ≥ 90 cm for females; systolic BP ≥ 130 
mmHg or diastolic BP ≥ 85 mmHg; triglycerides 
≥ 150 mg/dL or HDL < 40 mg/dL in males and 
< 50 mg/dL in females; FPG ≥ 100 mg/dL. Central 
obesity was defined as a BMI > 25 kg/m2, similar 
to the NCEP-ATP III definition. Furthermore, the 
Japanese definition stipulates that all subjects re-
ceiving pharmacological treatment for hypertension 
were considered to have elevated BP, all subjects 
receiving fibrates were considered to have elevated 
triglycerides levels, and all subjects previously diag-
nosed with T2DM were considered to have raised 
FPG.
Identification of FTO polymorphism
 
Peripheral blood samples, which had been collected 
for the health check-up in 1998 and remained af-
ter blood tests, were used for the identification of 
three SNPs rs9939609, rs1121980 and rs1558902 
in the FTO. Genomic DNA was extracted from 
these samples using a QIAamp DNA Blood Kit 
Table 1a. Clinical characteristics per genotype in rs9939609 
 
 TT TA AA  TT + TA TA + AA All P P P
       value* value† value‡
 NCEP-ATPIII
Number  570 251 38 821 570 859
Age (yr) 37.76 ± 8.59 37.32 ± 9.13 39.07 ± 8.56 37.63 ± 8.75 37.55 ± 9.06 37.69 ± 8.74 0.487  0.740  0.318
BMI (kg/m2) 22.09 ± 2.98 22.54 ± 3.22 23.32 ± 3.52 22.23 ± 3.06 22.64 ± 3.26 22.28 ± 3.09 0.018  0.015  0.034
SBP (mmHg) 115.29 ± 14.69 116.05 ± 15.58 116.95 ± 12.33 115.52 ± 14.96 116.17 ± 15.17 115.58 ± 14.85 0.672  0.411 0.563
DBP (mmHg) 71.61 ± 10.54 71.92 ± 10.71 72.32 ± 11.36 71.7 ± 10.58 71.97 ± 10.77 71.73 ± 10.61 0.874  0.636 0.728
HDL-C (mg/dL) 66.61 ± 17.26 65.39 ± 16.64 69.45 ± 14.38 66.24 ± 17.06 65.93 ± 16.39 66.38 ± 16.96 0.335  0.580 0.254
TG (mg/dL) 95.96 ± 66.78 93.98 ± 59.06 89.63 ± 50.89 95.36 ± 64.48 93.4 ± 57.99 95.1 ± 63.93 0.795  0.580 0.590
FPG (mg/dL) 95.66 ± 13.33 95.88 ± 17.28 96.55 ± 10.77 95.72 ± 14.64 95.97 ± 16.56 95.76 ± 14.49 0.924  0.768 0.730
 Japanese definition
Number   573 253 39 826 292 865
Age  (yr) 37.79 ± 8.55 37.45 ± 9.13 39.1 ± 8.46 37.69 ± 8.73 37.67 ± 9.05 37.75 ± 8.72 0.533 0.841  0.322
BMI (kg/m2) 22.14 ± 2.98 22.56 ± 3.05 23.42 ± 3.52 22.27 ± 3.01 22.67 ± 3.12 22.32 ± 3.04 0.013 0.015  0.021
SBP (mmHg) 115.46 ± 14.72 116.08 ± 15.3 117.13 ± 12.22 115.65 ± 14.9 116.22 ± 14.91 115.71 ± 14.78 0.712 0.476 0.541
DBP (mmHg) 71.72 ± 10.6 72.04 ± 10.67 72.62 ± 11.36 71.82 ± 10.62 72.12 ± 10.75 71.85 ± 10.65 0.833 0.606 0.648
HDL-C (mg/dL) 66.16 ± 17.47 64.97 ± 16.98 68.64 ± 15.06 65.79 ± 17.32 65.46 ± 16.76 65.92 ± 17.23 0.396 0.573 0.313
TG (mg/dL) 98.91 ± 72.86 96.39 ± 61.41 93.69 ± 56.26 98.14 ± 69.52 96.03 ± 60.66 97.94 ± 68.96 0.823 0.561 0.694
FPG  (mg/dL) 95.64 ± 13.17 95.99 ± 17.3 96.72  ± 10.68 95.75 ± 14.55 96.09 ± 16.56 95.79 ± 14.4 0.873 0.666 0.681
 Data are numbers of subjects, divided into genotype groups, and values are mean ± SD.
 BMI, body mass index; DBP, diastolic blood pressure; FPG, fasting plasma glucose; HDL-C, high density lipoprotein-cholesterol; 
NCEP-ATPIII, National Cholesterol Education Program-Adult Treatment panel III; SBP, systolic blood pressure; TG, triglyceride.
* Additive model (analysis of variance): comparison among 3 groups (TT versus TA versus AA). 
† Dominant model (t-test): comparison of TT + TA with AA.
‡ Recessive model (t-test): comparison of TT with TA + AA. 
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(Qiagen, Hilden, Germany). These SNPs were 
genotyped using TaqMan PCR methods with the 
following probes: C_30090620_10 for rs9939609, 
C_2031261_10 for rs1121980 and C_891711_10 for 
rs1558902 (Applied Biosystems, Foster City, CA).
 
 
Table 1b. Lifestyle characteristics per genotypes in rs9939609
 
 TT TA AA  TT + TA TA + AA All P P P
       value* value† value‡
 NCEP-ATPIII
Sex
 Male 321 (56.3) 147 (58.6) 18 (47.4) 468 (57.0) 165 (57.1) 486 (56.6) 0.421  0.828  0.241 
 Female 249 (43.7) 104 (41.4) 20 (52.6) 353 (43.0) 124 (42.9) 373 (43.4)
Alchol drinking habit
 No drinking 252 (44.4) 101 (40.6) 22 (59.5) 353 (43.3) 123 (43.0) 375 (44.0) 0.300 0.914 0.149
 Occasionally 178 (31.4) 83 (33.3) 8 (21.6) 261 (32.0) 91 (31.8) 269 (31.5)
 Nearly every day 137 (24.2) 65 (26.1) 7 (18.9) 202 (24.8) 72 (25.2) 209 (24.5)
Smoking habit
 Never smoked 343 (60.3) 141 (56.2) 26 (68.4) 484 (59.0) 167 (57.8) 510 (59.4) 0.245  0.185  0.473
 Ex-smokers 23 (4.0) 18 (7.2) 2 (5.3) 41 (5.0) 20 (6.9) 43 (5.0)
 Current smokers 203 (35.7) 92 (36.7) 10 (26.3) 295 (36.0) 102 (35.3) 305 (35.5)
Balance of food 
 Eat various food 227 (40.0) 108 (43.0) 15 (39.5) 335 (40.9) 123 (42.6) 350 (40.8) 0.899  0.658  0.982
 Consider balance slightly 207 (36.4) 91 (36.3) 14 (36.8) 298 (36.4) 105 (36.3) 312 (36.4)
 Rarely consider balance 134 (23.6) 52 (20.7) 9 (23.7) 186 (22.7) 61 (21.1) 195 (22.8)
Exercise habit
 Frequently 38 (6.7) 20 (8.0) 2 (5.3) 58 (7.1) 22 (7.6) 60 (7.0) 0.943  0.849  0.900
 Sometimes 172 (30.2) 72 (28.7) 12 (31.6) 244 (29.8) 84 (29.1) 256 (29.8)
 No exercise 359 (63.1) 159 (63.3) 24 (63.2) 518 (63.2) 183 (63.3) 542 (63.2)
Sleeping habit
 Suficiently 93 (16.3) 48 (19.2) 7 (18.4) 141 (17.2) 55 (19.1) 148 (17.3) 0.671  0.502  0.526
 Normal 411 (72.2) 176 (70.4) 29 (76.3) 587 (71.7) 205 (71.2) 616 (71.9)
 Insufficiently 65 (11.4) 26 (10.4) 2 (5.3) 91 (11.1) 28 (9.7) 93 (10.9) 
 Japanese definition 
Sex
 Male 328 (57.2) 151 (59.7) 19 (48.7) 479 (58.0) 170 (55.8) 498 (57.6) 0.419  0.783  0.252
 Female 245 (42.8) 102 (40.3) 20 (51.3) 347 (42.0) 122 (44.2) 367 (42.4)
Alchol drinking habit
 No drinking 251 (44.0) 103 (41.0) 22 (57.9) 354 (43.1) 125 (44.3) 376 (43.8) 0.425  0.975  0.200
 Occasionally 178 (31.2) 83 (33.1) 9 (23.7) 261 (31.8) 92 (31.1) 270 (31.4)
 Nearly every day 141 (24.7) 65 (25.9) 7 (18.4) 206 (25.1) 72 (24.6) 213 (24.8)
Smoking habit
 Never smoked 340 (59.4) 140 (55.3) 27 (69.2) 480 (58.2) 167 (60.4) 507 (58.7) 0.134  0.118  0.369 
 Ex-smokers 24 (4.2) 20 (7.9) 2 (5.1) 44 (5.3) 22 (3.9) 46 (5.3)
 Current smokers 208 (36.4) 93 (36.8) 10 (25.6) 301 (36.5) 103 (35.7) 311 (36.0)
Balance of food
  Eat various food 230 (40.3) 110 (43.5) 16 (41.0) 340 (41.3) 126 (43.2) 356 (41.3) 0.894  0.619  0.997
 Consider balance slightly 207 (36.3) 91 (36.0) 14 (35.9) 298 (36.2) 105 (37.8) 312 (36.2)
 Rarely consider balance 134 (23.5) 52 (20.6) 9 (23.1) 186 (22.6) 61 (19.0) 195 (22.6)
Exercise habit
 Frequently 39 (6.8) 19 (7.5) 2 (5.1) 58 (7.0) 21 (6.0) 60 (6.9) 0.965  0.897  0.895
 Sometimes 171 (29.9) 71 (28.1) 12 (30.8) 242 (29.3) 83 (28.9) 254 (29.4)
 No exercise 362 (63.3) 163 (64.4) 25 (64.1) 525 (63.6) 188 (65.2) 550 (63.7)
Sleeping habit
 Suficiently 93 (16.3) 49 (19.4) 7 (17.9) 142 (17.2) 56 (15.8) 149 (17.3) 0.579  0.382  0.507
 Normal 413 (72.2) 178 (70.6) 30 (76.9) 591 (71.7) 208 (70.2) 621 (72.0)
 Insufficiently 66 (11.5) 25 (9.9) 2 (5.1) 91 (11.0) 27 (9.3) 93 (10.8)
 
 (    ), %. 
 NCEP-ATPIII, National Cholesterol Education Program-Adult Treatment panel III. 
* Additive model. 
† Dominant model. 
‡ Recessive model (c2 test).
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Statistical analysis
 
We used Student’s t-test and analysis of variance 
to compare continuous variables and the c2 test to 
compare categorical variables. Quantitative vari-
ables were expressed as the mean ± SD. The hazard 
ratio and 95% confidence interval of each factor 
for incidence of MS were estimated by univariate 
and multivariate Cox proportional-hazards models 
adjusted for sex, age, smoking, drinking, exercise, 
eating and sleeping habits. The onset of metabolic 
syndrome was defined as the day of health check-
up when an employee had a diagnosis of metabolic 
syndrome. Analysis was performed using PASW 
Statistics 18 (SPSS Japan, Tokyo). The significance 
level was set to P values of less than 0.05.
  
 
Results
 
The distributions of genotype and characteristics 
of study subjects are shown in Tables 1 to 3. The 
relative frequencies of TT homozygote, TA het-
erozygote and AA homozygote in rs9939609 were 
66.4%, 29.2%, 4.4% and 66.2%, 29.3%, 4.5% ac-
cording to the NCEP-ATP III and Japanese defini-
tions, respectively. Those of GG, GA and AA in 
rs1121980 were 60.0%, 34.6%, 5.4% and 59.8%, 
34.7%, 5.5% according to the NCEP-ATP III and 
Japanese definitions, respectively. Those of TT, TA 
and AA in rs1558902 were 66.6%, 29.1%, 4.3% and 
66.5%, 29.1%, 4.4% according to the NCEP-ATP III 
and Japanese definitions, respectively. 
 In both the NCEP-ATP III and Japanese defi-
nitions, the three SNPs, rs9939609, rs1121980 and 
rs1558902, were significantly associated with the 
BMI, as shown in Tables 1a, 2a and 3a, but there 
was no association between genotypes and life-
styles, such as drinking, smoking, eating, exercise 
and sleeping habits. Moreover, for rs1121980 and 
rs1558902, there were significant differences on 
FPG.
 Results of univariate analyses of the hazard 
ratios for MS of gene polymorphism and the indices 
are shown in Table 4. According to the NCEP-ATP 
III definition, the hazard ratios of sex, age, additive 
Table 2a. Clinical characteristics per genotype in rs1121980 
 
 GG GA AA  GG + GA GA + AA All P P P
       value* value† value‡
 NCEP-ATPIII
Number  515 297 47 812 344 859
Age (yr) 37.72 ± 8.64 37.46 ± 8.94 38.83 ± 8.73 37.63 ± 8.75 37.65 ± 8.91 37.69 ± 8.74 0.607  0.910  0.360  
BMI (kg/m2) 22.11 ± 2.95 22.38 ± 3.15 23.6 ± 3.74 22.21 ± 3.03 22.55 ± 3.26 22.28 ± 3.08 0.005  0.040  0.003  
SBP (mmHg) 115.56 ± 14.76 115.53 ± 15.46 116.13 ± 11.84 115.55 ± 15.01 115.62 ± 15 115.58 ± 14.85 0.967  0.960  0.796  
DBP (mmHg) 71.72 ± 10.47 71.89 ± 10.88 70.85 ± 10.53 71.78 ± 10.62 71.75 ± 10.83 71.73 ± 10.61 0.822  0.967  0.559  
HDL-C (mg/dL) 66.57 ± 17.21 65.87 ± 16.89 67.43 ± 14.67 66.32 ± 17.09 66.08 ± 16.59 66.38 ± 16.96 0.773  0.676  0.663  
TG (mg/dL) 95.15 ± 63.12 95.58 ± 66.43 91.64 ± 57.41 95.3 ± 64.31 95.04 ± 65.21 95.1 ± 63.93 0.926  0.981  0.703  
FPG (mg/dL) 95.7 ± 13.54 95.1 ± 9.47 100.57 ± 35.5 95.48 ± 12.21 95.85 ± 15.81 95.76 ± 14.48 0.055  0.884  0.019  
 Japanese definition
Number  517 300 48 817 348 865
Age  (yr) 37.75 ± 8.61 37.57 ± 8.93 38.85 ± 8.64 37.69 ± 8.72 37.75 ± 8.89 37.75 ± 8.72 0.640  0.997  0.368  
BMI (kg/m2) 22.15 ± 2.96 22.4 ± 3.01 23.67 ± 3.73 22.24 ± 2.98 22.57 ± 3.15 22.32 ± 3.04 0.003  0.044  0.001  
SBP (mmHg) 115.76 ± 14.8 115.54 ± 15.22 116.29 ± 11.78 115.68 ± 14.95 115.64 ± 14.78 115.71 ± 14.78 0.942  0.910  0.781
DBP (mmHg) 71.84 ± 10.56 72 ± 10.84 71.13 ± 10.6 71.9 ± 10.66 71.88 ± 10.8 71.85 ± 10.65 0.869  0.955  0.626
HDL-C (mg/dL) 66.14 ± 17.41 65.4 ± 17.26 66.81 ± 15.13 65.87 ± 17.35 65.59 ± 16.97 65.92 ± 17.23 0.782  0.645  0.713
TG (mg/dL) 97.86 ± 69.19 98.55 ± 69.94 94.9 ± 61.12 98.12 ± 69.42 98.05 ± 68.72 97.94 ± 68.96 0.943  0.970  0.753  
FPG  (mg/dL) 95.64 ± 13.36 95.27 ± 9.64 100.63 ± 35.12 95.51 ± 12.12 96.01 ± 15.83 95.79 ± 14.4 0.053  0.717  0.017  
 
 Data are numbers of subjects, divided into genotype groups, and values are mean ± SD.
 BMI, body mass index; DBP, diastolic blood pressure; FPG, fasting plasma glucose; HDL-C, high density lipoprotein-cholesterol; 
NCEP-ATPIII, National Cholesterol Education Program-Adult Treatment panel III; SBP, systolic blood pressure; TG, triglyceride.
* Additive model (analysis of variance): comparison among 3 groups (GG versus GA versus AA). 
† Dominant model (t-test): comparison of GG + GA with AA.
‡ Recessive model (t-test): comparison of GG with GA + AA. 
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Table 2b. Lifestyle characteristics per genotypes in rs1121980 
 
 GG GA AA GG + GA GA + AA All P P P
       value* value† value‡
 NCEP-ATPIII
Sex
 Male 297 (57.7) 165 (55.6) 24 (51.1) 462 (56.9) 189 (54.9) 486 (56.6) 0.619  0.429  0.433  
 Female 218 (42.3) 132 (44.4) 23 (48.9) 350 (43.1) 155 (45.1) 373 (43.4)
Alchol drinking habit
 No drinking 216 (42.2) 132 (44.7) 27 (58.7) 348 (43.1) 159 (46.6) 375 (44.0) 0.111  0.205  0.092
 Occasionally 160 (31.3) 100 (33.9) 9 (19.6) 260 (32.2) 109 (32.0) 269 (31.5)
 Nearly every day 136 (26.6) 63 (21.4) 10 (21.7) 199 (24.7) 73 (21.4) 209 (24.5)
Smoking habit
 Never smoked 301 (58.6) 179 (60.3) 30 (63.8) 480 (59.2) 209 (60.8) 510 (59.4) 0.649  0.739  0.325 
 Ex-smokers 25 (4.9) 14 (4.7) 4 (8.5) 39 (4.8) 18 (5.2) 43 (5.0)
 Current smokers 188 (36.6) 104 (35.0) 13 (27.7) 292 (36.0) 117 (34.0) 305 (35.5)
Balance of food 
 Eat various food 209 (40.7) 123 (41.4) 18 (38.3) 332 (41.0) 141 (41.0) 350 (40.8) 0.621  0.983  0.285
 Consider balance slightly 188 (36.6) 110 (37.0) 14 (29.8) 298 (36.8) 124 (36.0) 312 (36.4)
 Rarely consider balance 116 (22.6) 64 (21.5) 15 (31.9) 180 (22.2) 79 (23.0) 195 (22.8)
Exercise habit
 Frequently 35 (6.8) 23 (7.7) 2 (4.3) 58 (7.2) 25 (7.3) 60 (7.0) 0.846  0.906  0.656
 Sometimes 156 (30.4) 84 (28.3) 16 (34.0) 240 (29.6) 100 (29.1) 256 (29.8)
 No exercise 323 (62.8) 190 (64.0) 29 (61.7) 513 (63.3) 219 (63.7) 542 (63.2)
Sleeping habit
 Suficiently 87 (16.9) 51 (17.2) 10 (21.3) 138 (17.0) 61 (17.8) 148 (17.3) 0.609  0.948  0.286
 Normal 371 (72.2) 210 (70.9) 35 (74.5) 581 (71.7) 245 (71.4) 616 (71.9)
 Insufficiently 56 (10.9) 35 (11.8) 2 (4.3) 91 (11.2) 37 (10.8) 93 (10.9) 
 Japanese definition 
Sex
 Male 303 (58.6) 170 (56.7) 25 (52.1) 473 (57.9) 195 (56.0) 498 (57.6) 0.631  0.453  0.429 
 Female 214 (41.4) 130 (43.3) 23 (47.9) 344 (42.1) 153 (44.0) 367 (42.4)
Alchol drinking habit
 No drinking 214 (41.6) 135 (45.3) 27 (57.4) 349 (43.0) 162 (47.0) 376 (43.8) 0.101  0.108  0.135 
 Occasionally 160 (31.1) 100 (33.6) 10 (21.3) 260 (32.0) 110 (31.9) 270 (31.4)
 Nearly every day 140 (27.2) 63 (21.1) 10 (21.3) 203 (25.0) 73 (21.2) 213 (24.8)
Smoking habit
 Never smoked 298 (57.8) 178 (59.3) 31 (64.6) 476 (58.3) 209 (60.1) 507 (58.7) 0.630  0.635  0.319  
 Ex-smokers 26 (5.0) 16 (5.3) 4 (8.3) 42 (5.1) 20 (5.7) 46 (5.3)
 Current smokers 192 (37.2) 106 (35.3) 13 (27.1) 298 (36.5) 119 (34.2) 311 (36.0)
Balance of food
  Eat various food 211 (41.0) 126 (42.0) 19 (39.6) 337 (41.3) 145 (41.7) 356 (41.3) 0.631  0.965  0.300 
 Consider balance slightly 188 (36.5) 110 (36.7) 14 (29.2) 298 (36.6) 124 (35.6) 312 (36.2)
 Rarely consider balance 116 (22.5) 64 (21.3) 15 (31.3) 180 (22.1) 79 (22.7) 195 (22.6)
Exercise habit
 Frequently 36 (7.0) 22 (7.3) 2 (4.2) 58 (7.1) 24 (6.9) 60 (6.9) 0.851  0.873  0.656 
 Sometimes 155 (30.0) 83 (27.7) 16 (33.3) 238 (29.2) 99 (28.4) 254 (29.4)
 No exercise 325 (63.0) 195 (65.0) 30 (62.5) 520 (63.7) 225 (64.7) 550 (63.7)
Sleeping habit
 Suficiently 87 (16.9) 52 (17.4) 10 (20.8) 139 (17.1) 62 (17.9) 149 (17.3) 0.632  0.899  0.286 
 Normal 372 (72.1) 213 (71.2) 36 (75.0) 585 (71.8) 249 (71.8) 621 (72.0)
 Insufficiently 57 (11.0) 34 (11.4) 2 (4.2) 91 (11.2) 36 (10.4) 93 (10.8)
 
 (    ), %. 
 NCEP-ATPIII, National Cholesterol Education Program-Adult Treatment panel III.
* Additive model. 
† Dominant model.
‡ Recessive model (c2 test). 
and dominant models of rs9939609 and rs1121980 
and the dominant model of rs1558902 were signifi-
cantly high. According to the Japanese definition, 
that of only sex was significantly high. In both defi-
nitions, drinking and smoking habits showed sig-
nificantly high risks, but regarding balance of food, 
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considering balance showed a significantly low risk.
 After adjusting for age, sex and lifestyle 
(drinking, smoking, eating, exercise and sleeping 
habit), results of multivariate analysis are shown in 
Table 5. According to the NCEP-ATP III definition, 
results were almost the same as single variant anal-
ysis. But the hazard ratio was significantly higher 
in the additive model of rs1558902. In the Japanese 
definition, the additive model of rs1558902 was a 
significant high risk for MS. 
 
Discussion
 
In the present study, a retrospective cohort study 
over 9 years was performed in Japanese work-
ers to investigate the association of three SNPs, 
rs9939609, rs1121980 and rs1558902, in the FTO 
with the incidence of MS diagnosed by the NCEP-
ATPIII and Japanese definitions.
 The frequencies of genotypes and alleles in the 
FTO were similar to those in other studies in Japa-
nese (Hotta et al., 2008; Shimaoka et al., 2010). In 
contrast, those of genotypes and alleles in other eth-
nic groups were remarkably different from those in 
Japanese. By the HapMap database (http://hapmap.
ncbi.nlm.nih.gov/), the frequencies of the rs9939609 
A allele were 0.14 in Chinese and Japanese, 0.45 in 
CEPH Europeans and 0.52 in Yorubans. Therefore, 
the effect and importance of genetic factors makes 
differences among ethnic groups.
 According to the NCEP-ATPIII definition, the 
three SNPs in the FTO were significantly associated 
with BMI. Moreover, rs1121980 and rs1558902 were 
associated with FPG. These results were consistent 
with previous studies (Horikoshi et al., 2007; Hotta 
et al., 2008; Tabara et al., 2009; Hotta et al., 2010; 
Shimaoka et al., 2010). However, in both the NCEP-
ATPIII and Japanese definitions, none of the three 
SNPs were associated with sex and lifestyle (drink-
ing, smoking, eating, exercise and sleeping habit). 
The three SNPs clarified by not only univariate, but 
also multivariate analysis adjusting for age, sex and 
lifestyle were significantly associated with the inci-
dence of MS diagnosed by the NCEP-ATPIII defi-
nition. By the Japanese definition, only rs1558902 
Table 3a. Clinical characteristics per genotype in rs1558902
 
 TT TA AA  TT + TA TA + AA All P P P
       value* value† value‡
 NCEP-ATPIII
Number  572 250 37 822 287 859
Age (yr) 37.73 ± 8.58 37.36 ± 9.14 39.41 ± 8.54 37.62 ± 8.75 37.62 ± 9.08 37.69 ± 8.74 0.407  0.864  0.224   
BMI (kg/m2) 22.08 ± 2.92 22.55 ± 3.25 23.58 ± 3.95 22.22 ± 3.03 22.68 ± 3.36 22.28 ± 3.08 0.005  0.008  0.009   
SBP (mmHg) 115.37 ± 14.78 115.86 ± 15.41 117.03 ± 12.14 115.52 ± 14.96 116.01 ± 15.01 115.58 ± 14.85 0.757  0.548  0.546  
DBP (mmHg) 71.62 ± 10.59 71.93 ± 10.6 72.16 ± 11.17 71.71 ± 10.59 71.96 ± 10.65 71.73 ± 10.61 0.899  0.658  0.801  
HDL-C (mg/dL) 66.73 ± 17.3 65.14 ± 16.45 69.3 ± 14.69 66.25 ± 17.05 65.67 ± 16.27 66.38 ± 16.96 0.262  0.389  0.285  
TG (mg/dL) 95.08 ± 63.8 95.72 ± 66.03 91.35 ± 51.67 95.27 ± 64.45 95.16 ± 64.29 95.1 ± 63.93 0.928  0.986  0.715   
FPG (mg/dL) 95.47 ± 13.07 95.36 ± 9.79 102.95 ± 39.64 95.44 ± 12.16 96.34 ± 16.96 95.76 ± 14.48 0.008  0.405  0.002  
 Japanese definition
Number  575 252 38 827 290 865
Age  (yr) 37.76 ± 8.55 37.48 ± 9.15 39.42 ± 8.43 37.67 ± 8.73 37.73 ± 9.06 37.75 ± 8.72 0.441  0.968  0.228  
BMI (kg/m2) 22.12 ± 2.92 22.56 ± 3.09 23.67 ± 3.94 22.26 ± 2.98 22.71 ± 3.23 22.32 ± 3.04 0.003  0.008  0.005   
SBP (mmHg) 115.54 ± 14.81 115.89 ± 15.14 117.21 ± 12.03 115.64 ± 14.9 116.06 ± 14.76 115.71 ± 14.78 0.777  0.622  0.523   
DBP (mmHg) 71.73 ± 10.66 72.05 ± 10.57 72.47 ± 11.19 71.83 ± 10.63 72.1 ± 10.63 71.85 ± 10.65 0.865  0.625  0.714 
HDL-C (mg/dL) 66.28 ± 17.52 64.71 ± 16.79 68.47 ± 15.36 65.8 ± 17.31 65.2 ± 16.63 65.92 ± 17.23 0.312  0.384  0.351 
TG (mg/dL) 98.02 ± 70.18 98.13 ± 68.03 95.47 ± 56.95 98.05 ± 69.49 97.78 ± 66.6 97.94 ± 68.96 0.975  0.962  0.822   
FPG  (mg/dL) 95.45 ± 12.92 95.48 ± 9.92 102.95 ± 39.11 95.46 ± 12.08 96.46 ± 16.96 95.79 ± 14.4 0.007  0.332  0.002  
 
 Data are numbers of subjects, divided into genotype groups, and values are mean ± SD.
 BMI, body mass index; DBP, diastolic blood pressure; FPG, fasting plasma glucose; HDL-C, high density lipoprotein-cholesterol; 
NCEP-ATPIII, National Cholesterol Education Program-Adult Treatment panel III; SBP, systolic blood pressure; TG, triglyceride.
* Additive model (analysis of variance): comparison among 3 groups (TT versus TA versus AA). 
† Dominant model (t-test): comparison of TT + TA with AA.
‡ Recessive model (t-test): comparison of TT with TA + AA. 
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was significantly associated with MS. Moreover, in 
rs1121980 and rs1558902, the hazard ratio for MS 
by the NCEP-ATPIII definition became higher as 
the number of risk alleles increased. Thus, it was 
suggested that the A allele at three SNPs is a risk 
allele and is at substantially increased risk of MS.  
Table 3b. Lifestyle characteristics per genotypes in rs1558902
 
 TT TA AA  TT + TA TA + AA All P P P
       value* value† value‡
 NCEP-ATPIII
Sex
 Male 327 (57.2) 142 (56.8) 17 (45.9) 469 (57.1) 159 (55.4) 486 (56.6) 0.409  0.622  0.182
 Female 245 (42.8) 108 (43.2) 20 (54.1) 353 (42.9) 128 (44.6) 373 (43.4)
Alcohol drinking habit
 No drinking 246 (43.2) 107 (43.1) 22 (61.1) 353 (43.2) 129 (45.4) 375 (44.0) 0.274 0.718 0.098
 Occasionally 179 (31.5) 83 (33.5) 7 (19.4) 262 (32.1) 90 (31.7) 269 (31.5)
 Nearly every day 144 (25.3) 58 (23.4) 7 (19.4) 202 (24.7) 65 (22.9) 209 (24.5)
Smoking habit
 Never smoked 340 (59.5) 144 (57.6) 26 (70.3) 484 (59.0) 170 (59.2) 510 (59.4) 0.659  0.979  0.342 
 Ex-smokers 28 (4.9) 13 (5.2) 2 (5.4) 41 (5.0) 15 (5.2) 43 (5.0)
 Current smokers 203 (35.6) 93 (37.2) 9 (24.3) 296 (36.1) 102 (35.5) 305 (35.5)
Balance of food 
 Eat various food 227 (39.8) 108 (43.2) 15 (40.5) 335 (40.9) 123 (42.9) 350 (40.8) 0.890  0.641  0.970
  Consider balance slightly 209 (36.7) 90 (36.0) 13 (35.1) 299 (36.5) 103 (35.9) 312 (36.4)
 Rarely consider balance 134 (23.5) 52 (20.8) 9 (24.3) 186 (22.7) 61 (21.3) 195 (22.8)
Exercise habit
 Frequently 39 (6.8) 19 (7.6) 2 (5.4) 58 (7.1) 21 (7.3) 60 (7.0) 0.936  0.837  0.890 
 Sometimes 174 (30.5) 70 (28.0) 12 (32.4) 244 (29.7) 82 (28.6) 256 (29.8)
 No exercise 358 (62.7) 161 (64.4) 23 (62.2) 519 (63.2) 184 (64.1) 542 (63.2)
Sleeping habit
 Sufficiently 94 (16.5) 48 (19.3) 6 (16.2) 142 (17.3) 54 (18.9) 148 (17.3) 0.675  0.673  0.520 
 Normal 414 (72.5) 173 (69.5) 29 (78.4) 587 (71.6) 202 (70.6) 616 (71.9)
 Insufficiently 63 (11.0) 28 (11.2) 2 (5.4) 91 (11.1) 30 (10.5) 93 (10.9)
Japanese definition 
Sex
 Male 334 (58.1) 146 (57.9) 18 (47.4) 480 (58.0) 164 (56.6) 498 (57.6) 0.428  0.666  0.193 
 Female 241 (41.9) 106 (42.1) 20 (52.6) 347 (42.0) 126 (43.4) 367 (42.4)
Alcohol drinking habit
 No drinking 245 (42.8) 109 (43.6) 22 (59.5) 354 (43.1) 131 (45.6) 376 (43.8) 0.328  0.560  0.143 
 Occasionally 179 (31.3) 83 (33.2) 8 (21.6) 262 (31.9) 91 (31.7) 270 (31.4)
 Nearly every day 148 (25.9) 58 (23.2) 7 (18.9) 206 (25.1) 65 (22.6) 213 (24.8)
Smoking habit
 Never smoked 337 (58.7) 143 (56.7) 27 (71.1) 480 (58.1) 170 (58.6) 507 (58.7) 0.533  0.876  0.258 
 Ex-smokers 29 (5.1) 15 (6.0) 2 (5.3) 44 (5.3) 17 (5.9) 46 (5.3)
 Current smokers 208 (36.2) 94 (37.3) 9 (23.7) 302 (36.6) 103 (35.5) 311 (36.0)
Balance of food 
 Eat various food 230 (40.1) 110 (43.7) 16 (42.1) 340 (41.2) 230 (40.1) 356 (41.3) 0.877  0.597  0.966 
 Consider balance slightly 209 (36.5) 90 (35.7) 13 (34.2) 299 (36.2) 209 (36.5) 312 (36.2)
 Rarely consider balance 134 (23.4) 52 (20.6) 9 (23.7) 186 (22.5) 134 (23.4) 195 (22.6)
Exercise habit
 Frequently 40 (7.0) 18 (7.1) 2 (5.3) 58 (7.0) 20 (6.9) 60 (6.9) 0.929  0.787  0.892 
 Sometimes 173 (30.1) 69 (27.4) 12 (31.6) 242 (29.3) 81 (27.9) 254 (29.4)
 No exercise 361 (62.9) 165 (65.5) 24 (63.2) 526 (63.7) 189 (65.2) 550 (63.7)
Sleeping habit
 Sufficiently 94 (16.4) 49 (19.5) 6 (15.8) 143 (17.3) 55 (19.0) 149 (17.3) 0.618  0.586  0.486 
 Normal 416 (72.5) 175 (69.7) 30 (78.9) 591 (71.6) 205 (70.9) 621 (72.0)
 Insufficiently 64 (11.1) 27 (10.8) 2 (5.3) 91 (11.0) 29 (10.0) 93 (10.8)
 
 (    ), %. 
 NCEP-ATPIII, National Cholesterol Education Program-Adult Treatment panel III. 
* Additive model. 
† Dominant model. 
‡ Recessive model (c2 test).
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 In the present study, we showed an associa-
tion between SNPs FTO and MS diagnosed by 
the NCEP-ATP III and Japanese definitions which 
disagreed with the results of Shimaoka et al. (2010) 
and Tabara et al. (2009). However, according to the 
NCEP-ATP III definition used internationally, this 
study were consistent with the results of Sjögren 
et al. (2008) and Al-Attar et al. (2008) in Swedish, 
French, Inuit, and Chinese specific ethnic groups 
(Table 6). To investigate the importance of FTO 
SNPs in Japanese populations, further studies should 
be carried out in more extensive Japanese subjects. 
 The average of BMI in subjects was 22.3 ± 
3.1 kg/m2, which is close to the Japanese average of 
around 30 years of age. The hazard ratios of life-
style for MS in univariate analysis were not signifi-
cantly associated with food, exercise and sleeping 
habits. Lifestyle is known as a risk factor of MS, 
but an association with these habits was not found; 
however, we performed the investigation in 1998 
and as for these lifestyles, we speculate the index 
easily changed during the 9 years between 1998 and 
Table 4.  Hazard ratios of gender, age and lifestyle for MS by genotype (univariate analysis)
 NCEP-ATPIII Japanese definition
 Hazard 95% P Hazard 95% P
 ratio CI value ratio CI value
Sex Female  1.00    1.00 
 Male  4.46  2.95–6.74 0.00  7.01 3.86–12.75 0
Age   1.02  1.00–1.04 0.02  1.01 0.99–1.03 0.53
rs9939609 Additive model TT 1.00    1.00 
  TA 1.52  1.10–2.08 0.01  1.38  0.93–2.03 0.10 
  AA 1.31  0.63–2.70 0.46  1.33  0.58–3.05 0.51 
 Dominant model TT 1.00    1.00 
  TA + AA 1.49  1.09–2.02 0.01  1.37 0.95–1.99 0.09
 Recessive model TT + TA 1.00    1.00 
  AA 1.140 0.56–2.32 0.72  1.19 0.52–2.71 0.68
rs1121980 Additive model GG 1.00    1.00 
  GA 1.57  1.14–2.16 0.01  1.19 0.80–1.74 0.39
  AA 1.78  0.92–3.41 0.08  1.82 0.93–3.55 0.07
 Dominant model GG 1.00    1.00 
  GA + AA 1.60  1.17–2.16 0.00  1.27 0.88–1.83 0.2
 Recessive model GG + GA 1.00    1.00 
  AA 1.520 0.80–2.89 0.20  1.7 0.89–3.26 0.11
rs1558902 Additive model TT 1.00    1.00 
  TA 1.33  0.97–1.83 0.08  1.37 0.93–2.03 0.11
  AA 1.76  0.98–3.15 0.06  1.88 0.9–3.91 0.09
 Dominant model TT 1.00    1.00 
  TA + AA 1.39  1.02–1.88 0.04  1.44 0.99–2.08 0.05
 Recessive model AT + TT 1.00    1.00 
  AA 1.57  0.89–2.77 0.12  1.69 0.82–3.47 0.15
Alchol drinking habit No drinking  1.00    1.00 
 Occasionally  1.70  1.16–2.49 0.01  1.37 0.87–2.15 0.18
 Nearly every day  2.36  1.62–3.45 0.00  1.99 1.28–3.10 0
Smoking habit Never smoked  1.00    1.00 
 Ex-smokers  1.30  0.59–2.83 0.51  1.92  0.86–4.28 0.11
 Current smokers  2.81  2.05–3.85 0.00  2.92  1.98–4.30 0
Balance of food  Eat various food  1.00    1.00 
 Consider balance slightly 0.57  0.39–0.83 0.00  0.62 0.39–0.96 0.03
 Rarely consider balance 1.01  0.70–1.45 0.97  0.99 0.64–1.55 0.97
Exercise habit Frequently  1.00    1.00 
 Sometimes  1.01  0.54–1.90 0.96  1.05 0.51–2.17 0.89
 No exercise  0.94  0.52–1.71 0.84  0.8 0.4–1.61 0.53
Sleeping habit Suficiently  1.00    1.00 
 Normal  0.75  0.52–1.10 0.14  0.96 0.60–1.55 0.88
 Insufficiently  0.68  0.38–1.22 0.20  0.83 0.40–1.71 0.6
CI, confidence interval; MS, metabolic syndrome; NCEP-ATPIII, National Cholesterol Education Program-Adult Treatment panel III. 
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Table 5.  Hazard ratios of gender, age and lifestyle for MS by genotype (multivariate analysis)
 Genotype NCEP-ATPIII   Japanese definition
  Hazard ratio 95% CI P value Hazard ratio 95% CI P value
rs9939609 Additive model TT 1.00   1.00
  TA 1.48 1.07–2.04 0.02 1.35  0.91–2.00 0.13
  AA 1.48 0.72–3.07 0.29 1.54  0.66–3.57 0.32
 Dominant model TT 1.00   1.00
  TA + AA 1.48 1.08–2.02 0.01 1.37  0.94–2.00 0.10
 Recessive model TT + TA 1.00   1.00
  AA 1.29 0.63–2.63 0.49 1.38  0.60–3.18 0.44
rs1121980 Additive model GG 1.00   1.00
  GA 1.55 1.12–2.14 0.01 1.19  0.81–1.76 0.38
  AA 2.06 1.07–3.99 0.03 1.99  1.00–3.94 0.05
 Dominant model GG 1.00   1.00
  GA + AA 1.60 1.18–2.19 0.00 1.29  0.89–1.86 0.18
 Recessive model GG + GA 1.00   1.00
  AA 1.76 0.93–3.37 0.08 1.86  0.96–3.61 0.07
rs1558902 Additive model TT 1.00   1.00
  TA 1.35 0.98–1.86 0.07 1.37  0.93–2.04 0.12
  AA 1.88 1.04–3.40 0.04  2.24  1.07–4.72 0.03
 Dominant model TT 1.00   1.00
  TA + AA 1.41 1.04–1.92 0.03 1.47  1.01–2.13 0.05
 Recessive model AT + TT 1.00   1.00
  AA 1.67 0.94–2.97 0.08  2.01 0.97–4.17 0.06
Adjusted for sex, age and lifestyle (drinking, smoking, eating, exercise and sleeping habits).
CI, confidence interval; MS, metabolic syndrome; NCEP-ATPIII, National Cholesterol Education Program-Adult Treatment panel III. 
2006. Thus, lifestyles varied with the incidence of 
MS. According to alcohol and smoking habits, there 
were significant associations with MS. Lifestyle is 
the factor that is hard to be changed and it strongly 
affects the onset of MS.
 It was reported that risk allele carriers were 3 kg 
heavier than non-carriers (Dina et al., 2007; Frayling 
et al., 2007). It has been reported that lifestyle altera-
tions can reduce the risk of MS (Fappa et al., 2008), 
even in individuals carrying the MS-susceptibility 
variant of FTO. Therefore, genotyping SNPs of FTO 
in an individual may be effective for personalized 
preventive medicine in Japanese populations.
 In the present study, we could not determine 
the mechanism of FTO SNPs affecting the preva-
lence of MS. So far, the function of the FTO was 
revealed gradually, and there was evidence that 
the FTO was involved in the development of obe-
sity. FTO mRNA was widely expressed in fetal 
and adult tissues, especially in the brain, and in 
particular the hypothalamus, which is involved in 
energy balance (Dina et al., 2007; Frayling et al., 
2007; Gerken et al., 2007). Moreover, several stud-
ies suggested that risk-allele carriers had greater 
food intake in human subjects (Cecil et al., 2008; 
Speakman et al., 2008), but not all (Tanofsky-Kraff 
et al., 2009). The risk-allele in human FTO may 
enhance the expression and/or activity of the FTO 
(Church et al., 2010). Thus, overexpression of the 
FTO may lead to increased food intake, resulting 
in obesity. However, the precise mechanism of how 
the FTO affects obesity and MS is not clear yet.
 Most reports which have studied the relation-
ship between polymorphism in the FTO and MS 
were analyzed using case-control or cross-sectional 
studies (Al-Attar et al., 2008; Tabara et al., 2009; 
Shimaoka et al., 2010) (Table 6). A retrospective co-
hort study among workers, not hospital-based, was 
employed in the present study. Although a cohort 
study was employed to reduce the effect of biases 
compared to the case-control study, some limitations 
remain. First, the relatively young subject population 
and healthy-worker effect due to selection of subjects 
after medical checkups at the time of employment 
may have decreased subjects with MS and affected 
the results of the study. Second, regarding the sam-
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Table 6.  Association of FTO genotype with MS
 Method Subject Definition of MS SNP Association
Present study Cohort study Japanese Japanese definition  rs9939609 –
  (Izumo region, Shimane)  rs1121980 –
    rs1558902 +
   NCEP-ATPIII rs9939609 +
    rs1121980 +
    rs1558902 +
Shimaoka et al., 2010 Cross-sectional study Japanese Japanese definition rs9939609 –
  (Tanno-Sobetsu, Hokkaido)  rs1121980 –
    rs1558902 –
Tabara et al., 2009 Case-control study Japanese NCEP-ATPIII rs9939609 –
  (Ehime)
Sjögren et al., 2008 Cohort study Swedish Ordinal rs9939609 +
   (reference to NCEP-ATPIII, IDF)
Al-Attar et al., 2008 Meta-analysis South Asian IDF rs9939609 +
  Chinese   –
  Oji-Cree   –
  Greenland Inuit   –
  South Asian NCEP-ATPIII rs9939609 –
  Chinese   –
  Oji-Cree   –
  Greenland Inuit   +
FTO, fat mass and obesity associated gene; IDF, International Diabetes Federation; MS, metabolic syndrome; NCEP-ATPIII, National 
Cholesterol Education Program-Adult Treatment panel III; SNP, single nucleotide polymorphism. 
ple size, we could not recruit enough numbers of the 
risk A-allele homozygous genotype. Results present-
ed above need to be further verified with increased 
numbers. Because we did not have the data of ab-
dominal circumference of subjects, we used BMI 
for classification of Japanese metabolic syndrome 
in substitution for abdominal circumference. Since 
BMI ≥ 25 is a good surrogate measure of abdominal 
obesity among the Japanese population (Otsuka and 
Kawada, 2010), the effect of misclassification of the 
abdominal obesity to the study results is considered 
small.
 In our results, we indicated that rs9939609, 
rs1121980 and rs1558902 in the FTO may be sig-
nificantly associated with the incidence of MS di-
agnosed by the NCEP-ATP III in Japanese subjects, 
and by the Japanese definition the association ap-
plied to rs1558902.  It is considered that there is the 
linkage disequilibrium between three SNPs assessed 
in the present study; however, we did not assessed 
statistically. SNPs may be an important risk fac-
tor for the future incidence of MS in the Japanese. 
Therefore, knowing earlier whether individuals are 
risk allele carriers may be useful in preventing MS 
in the future.  
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